On November 14, 2015, the 10th participant was treated in our ongoing study of MDMA-assisted therapy for social anxiety in 12 adults on the autism spectrum. The 11th subject was enrolled on November 15. We plan to enroll one final subject in this study. “Unlike the PTSD studies, the social anxiety study includes interactions with the researchers that are intended to boost social confidence and provide practice opportunities to try new social skills in a safe setting,” report Principal Investigator Charles Grob, M.D., and Co-Investigator Alicia Danforth, Ph.D., in their new Winter 2015 MAPS Bulletin article. “Additionally, participants complete a video-based assessment of non-verbal social cues that involves watching actors in various social interactions.” Sponsored by MAPS, this is a collaborative study between MAPS and the Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, with blood plasma biomarker analysis being conducted by researchers at Stanford University.